Implementation of a pharmacy-driven rapid bacteremia response program

被引:4
作者
Wilde, Ashley M. [1 ]
Song, Matthew [1 ]
Allen, W. Paul [2 ]
Junkins, Alan D. [3 ]
Frazier, James M. [4 ]
Moore, Sarah E. [1 ]
Schulz, Paul S. [1 ]
机构
[1] Norton Infect Dis Inst, Norton Healthcare, Louisville, KY 40299 USA
[2] Norton Healthcare, Pharm Serv, Louisville, KY USA
[3] Norton Healthcare, Dept Microbiol, Louisville, KY USA
[4] Norton Healthcare, Med Affairs, Louisville, KY USA
关键词
antimicrobial stewardship; bacteremia; clinical pharmacy service; community hospitals; pharmacists; rapid diagnostic test; POLYMERASE-CHAIN-REACTION; IN-SITU HYBRIDIZATION; ANTIMICROBIAL STEWARDSHIP; ANTIBIOTIC-THERAPY; CLINICAL IMPACT; PCR ASSAY; IDENTIFICATION; TIME; OUTCOMES; DETERMINANT;
D O I
10.1093/ajhp/zxad211
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose This report describes a comprehensive pharmacy-driven rapid bacteremia response program.Summary This novel program positioned the pharmacy department at a large, community health system to receive and respond to critical microbiologic diagnostic testing results, 24/7/365. The program empowered pharmacists to provide centralized, comprehensive care including assessing blood culture Gram stain results, adjusting antibiotic therapy per protocol, ordering repeat blood cultures, analyzing and interpreting rapid molecular diagnostic test results, placing orders for contact isolation, and communicating antibiotic recommendations to the treatment team. In the first year after program implementation, 2,282 blood culture Gram stains and 2,046 rapid diagnostic test results were called in to the pharmacy department. The program reduced the median time to effective therapy in patients who did not already have active antimicrobial orders from over 10 hours to less than 1 hour. Based on the Gram stain results, antibiotics were started per protocol in 34.2% of patients. Based on the rapid molecular diagnostic test results, adjustments were made to antibiotic regimens in 55.7% of cases after discussion with a provider. Of these adjustments, 39.9% were for escalation of antibiotics and 37.7% were for de-escalation of antibiotics.Conclusion By expanding the scope of pharmacy practice, barriers to optimizing clinical care were overcome.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 27 条
[1]   Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs [J].
Bauer, Karri A. ;
Perez, Katherine K. ;
Forrest, Graeme N. ;
Goff, Debra A. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 :S134-S145
[2]   An Antimicrobial Stewardship Program's Impact with Rapid Polymerase Chain Reaction Methicillin- Resistant Staphylococcus aureus/S. aureus Blood Culture Test in Patients with S. aureus Bacteremia [J].
Bauer, Karri A. ;
West, Jessica E. ;
Balada-Llasat, Joan-Miquel ;
Pancholi, Preeti ;
Stevenson, Kurt B. ;
Goff, Debra A. .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (09) :1074-1080
[3]   Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia [J].
Bias, Tiffany E. ;
Vincent, William R. ;
Trustman, Nathan ;
Berkowitz, Leonard B. ;
Venugopalan, Veena .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (07) :511-519
[4]   Outcomes of Rapid Identification for Gram-Positive Bacteremia in Combination with Antibiotic Stewardship at a Community-Based Hospital System [J].
Box, Maggie J. ;
Sullivan, Eva L. ;
Ortwine, Kristine N. ;
Parmenter, Mark A. ;
Quigley, Michael M. ;
Aguilar-Higgins, Louise M. ;
MacIntosh, Cynthia L. ;
Goerke, Kristina F. ;
Lim, Rachel A. .
PHARMACOTHERAPY, 2015, 35 (03) :269-276
[5]   Examining the clinical impact of rapid multiplex polymerase chain reaction-based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration [J].
Britt, Nicholas S. ;
Khader, Karim ;
He, Tao ;
Willson, Tina M. ;
Effiong, Atim ;
Timbrook, Tristan T. ;
Potter, Emily M. ;
Lodise, Thomas P. .
PHARMACOTHERAPY, 2023, 43 (01) :24-34
[6]   Better Tests, Better Care: Improved Diagnostics for Infectious Diseases [J].
Caliendo, Angela M. ;
Gilbert, David N. ;
Ginocchio, Christine C. ;
Hanson, Kimberly E. ;
May, Larissa ;
Quinn, Thomas C. ;
Tenover, Fred C. ;
Alland, David ;
Blaschke, Anne J. ;
Bonomo, Robert A. ;
Carroll, Karen C. ;
Ferraro, Mary Jane ;
Hirschhorn, Lisa R. ;
Joseph, W. Patrick ;
Karchmer, Tobi ;
MacIntyre, Ann T. ;
Reller, L. Barth ;
Jackson, Audrey F. .
CLINICAL INFECTIOUS DISEASES, 2013, 57 :S139-S170
[7]  
Connors R., KENT SOC HLTH SYST P
[8]   Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs [J].
Forrest, G. N. ;
Mankes, K. ;
Jabra-Rizk, M. A. ;
Weekes, E. ;
Johnson, J. K. ;
Lincalis, D. P. ;
Venezia, R. A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) :3381-3383
[9]   Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: Delivering earlier effective antimicrobial therapy [J].
Forrest, Graeme N. ;
Roghmann, Mary-Claire ;
Toombs, Latoya S. ;
Johnson, Jennifer K. ;
Weekes, Elizabeth ;
Lincalis, Durry P. ;
Venezia, Richard A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) :3558-3563
[10]   Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures [J].
Forrest, Graerne N. ;
Mehta, Sanjay ;
Weekes, Elizabeth ;
Lincalis, Durry P. ;
Johnson, Jennifer K. ;
Venezia, Richard A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) :154-158